These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13526499)

  • 1. [Sympathoplegic therapy of Buerger's disease].
    SOLTESZ L; BOROCZ L; SZABO I
    Magy Belorv Arch (1955); 1957; 10(5-6):138-41. PubMed ID: 13526499
    [No Abstract]   [Full Text] [Related]  

  • 2. THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE).
    ABRAMSON DI
    Heart Bull; 1964; 13():48-51. PubMed ID: 14146982
    [No Abstract]   [Full Text] [Related]  

  • 3. [MAST CELLS OF THE SKIN IN ARTERIOSCLEROSIS OBLITERANS OF LOWER EXTREMITIES AND BUERGER'S DISEASE].
    WRZOLKOWA T
    Patol Pol; 1964; 15():445-50. PubMed ID: 14318883
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE DIAGNOSTIC PROBLEM OF BUERGER'S DISEASE. CRITICAL ANALYSIS WITH CASUISTIC REFERENCES].
    COTTI L; VIGLIERCHIO P
    Minerva Med; 1964 Apr; 55():1301-22. PubMed ID: 14163205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis obliterans and Buerger's disease].
    Ishimaru S; Yao Y
    Ryoikibetsu Shokogun Shirizu; 1996; (14):553-6. PubMed ID: 9047930
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T; Atsumi T
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract]   [Full Text] [Related]  

  • 7. A reconsideration of the pathogenesis of Buerger's disease.
    GORE I; BURROWS S
    Am J Clin Pathol; 1958 Apr; 29(4):319-30. PubMed ID: 13533321
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
    Sato T; Tamai H; Kobayashi M; Yamamoto K; Komori K
    Cardiovasc Pathol; 2011; 20(5):266-71. PubMed ID: 20708412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Buerger's disease and obliterative atherosclerosis. 2 different diseases].
    Puchmayer V; Pokorný J; Krcílek A
    Cas Lek Cesk; 1986 Oct; 125(43):1313-6. PubMed ID: 3508732
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of chlorpromazine in premedication, and association with regional blocks; a preliminary report.
    FAWCETT ER
    N Z Med J; 1955 Oct; 54(303):576-9. PubMed ID: 13288818
    [No Abstract]   [Full Text] [Related]  

  • 11. [Novocain block of the 3d left thoracic sympathetic ganglion in complex therapy of endarteritis obliterans].
    NIKOV NP
    Kazan Med Zh; 1961; 5():28-31. PubMed ID: 14479863
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of angiotrophin in the treatment of peripheral arteriosclerosis obliterans].
    BOUNOUS G; TATTONI G
    Minerva Cardioangiol; 1956 Sep; 4(9):566-74. PubMed ID: 13387018
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 14. [Balneotherapy of arterial diseases in Ciechocinek].
    SOSZKA A; KOWALSKA M; STASIAK L
    Pol Arch Med Wewn; 1958; 28(5):822-5. PubMed ID: 13601340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenic therapy of thromboangiitis obliterans (Buerger's disease)].
    NIKOLAKOV P
    Khirurgiia (Sofiia); 1959; 12(1):31-4. PubMed ID: 13642592
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetraethylammonium bromide in peripheral vascular disease and allied disorders; a new method of blocking the autonomic ganglia.
    CAMPBELL KN; LYONS RH
    Alexander Blain Hosp Bull; 1946 Aug; 5(3):105-14. PubMed ID: 21001526
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Buerger's disease or thromboangiitis obliterans revealed by an enteric ischemia. Case report and literature review].
    Adem C; Benamouzig R; Royer I; Chapel N; Martin A
    Gastroenterol Clin Biol; 2002 Apr; 26(4):409-11. PubMed ID: 12070415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy.
    Paraskevas KI; Liapis CD; Briana DD; Mikhailidis DP
    Angiology; 2007; 58(1):75-84. PubMed ID: 17351161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buerger's disease or Buerger's syndrome? An analysis of 12 cases.
    Scharf GM; van Wyk FA; Cloete GN; Rautenbach BK
    S Afr Med J; 1986 Dec; 70(13):803-5. PubMed ID: 3798265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.